Say Hello!
Don’t be shy.

 
0333 323 1843
 

[email protected]

 

BioCity Group HQ:
Pennyfoot Street
Nottingham
NG1 1GF

Phenotypeca

Phenotypeca

Home > Companies > Phenotypeca

Phenotypeca Ltd is a synthetic biology company combining yeast genomics technology with manufacturing expertise from the biopharmaceutical industry. Founded in 2018, Phenotypeca’s R&D operations are based in the Biodiscovery Institute’s Synthetic Biology Research Centre, University of Nottingham.

 

We use advance breeding of genetically diverse yeast to produce up to a billion novel strains for high-throughput screening. From these we select production strains with optimal phenotypes for future biomanufacturing processes. We are currently working on 3 research directions:

 

1. to optimise biologics production processes for cost reduction of vaccine production;

2. to develop yeast strains for the production of SARS-CoV-2 antigens to detect who has had COVID-19 in the UK population

3. developing next-generation baker’s yeast production strains for a coating for dialysis membranes.

These will be capable of preventing, at source, the blood’s foreign body reactions, and therefore improving long-term dialysis outcomes for patients.



X
X
X
X